156 related articles for article (PubMed ID: 18272194)
21. Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys.
Someya K; Xin KQ; Ami Y; Izumi Y; Mizuguchi H; Ohta S; Yamamoto N; Honda M; Okuda K
Virology; 2007 Oct; 367(2):390-7. PubMed ID: 17628628
[TBL] [Abstract][Full Text] [Related]
22. Vaccination of macaques with SIV immunogens delivered by Venezuelan equine encephalitis virus replicon particle vectors followed by a mucosal challenge with SIVsmE660.
Johnston RE; Johnson PR; Connell MJ; Montefiori DC; West A; Collier ML; Cecil C; Swanstrom R; Frelinger JA; Davis NL
Vaccine; 2005 Oct; 23(42):4969-79. PubMed ID: 16005121
[TBL] [Abstract][Full Text] [Related]
23. Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease.
McKenna PM; Koser ML; Carlson KR; Montefiori DC; Letvin NL; Papaneri AB; Pomerantz RJ; Dietzschold B; Silvera P; McGettigan JP; Schnell MJ
J Infect Dis; 2007 Apr; 195(7):980-8. PubMed ID: 17330788
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of SIV-lipopeptide immunizations administered by the intradermal route in their ability to induce antigen specific T-cell responses in rhesus macaques.
Coutsinos Z; Villefroy P; Gras-Masse H; Guillet JG; Bourgault-Villada I
FEMS Immunol Med Microbiol; 2005 Mar; 43(3):357-66. PubMed ID: 15708309
[TBL] [Abstract][Full Text] [Related]
25. Multiprotein genetic vaccine in the SIV-Macaca animal model: a promising approach to generate sterilizing immunity to HIV infection.
Maggiorella MT; Sernicola L; Crostarosa F; Belli R; Pavone-Cossut MR; Macchia I; Farcomeni S; Tenner-Racz K; Racz P; Ensoli B; Titti F
J Med Primatol; 2007 Aug; 36(4-5):180-94. PubMed ID: 17669207
[TBL] [Abstract][Full Text] [Related]
26. Comparative efficacy of subtype AE simian-human immunodeficiency virus priming and boosting vaccines in pigtail macaques.
De Rose R; Batten CJ; Smith MZ; Fernandez CS; Peut V; Thomson S; Ramshaw IA; Coupar BE; Boyle DB; Venturi V; Davenport MP; Kent SJ
J Virol; 2007 Jan; 81(1):292-300. PubMed ID: 17050602
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic immunization with Modified Vaccinia Virus Ankara (MVA) vaccines in SIV-infected rhesus monkeys undergoing antiretroviral therapy.
Uberla K; Rosenwirth B; Ten Haaft P; Heeney J; Sutter G; Erfle V
J Med Primatol; 2007 Feb; 36(1):2-9. PubMed ID: 17359459
[TBL] [Abstract][Full Text] [Related]
28. Kinetics of expansion of SIV Gag-specific CD8+ T lymphocytes following challenge of vaccinated macaques.
Abdel-Motal UM; Gillis J; Manson K; Wyand M; Montefiori D; Stefano-Cole K; Montelaro RC; Altman JD; Johnson RP
Virology; 2005 Mar; 333(2):226-38. PubMed ID: 15721357
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of recombinant influenza virus-simian immunodeficiency virus vaccines in macaques.
Sexton A; De Rose R; Reece JC; Alcantara S; Loh L; Moffat JM; Laurie K; Hurt A; Doherty PC; Turner SJ; Kent SJ; Stambas J
J Virol; 2009 Aug; 83(15):7619-28. PubMed ID: 19439474
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of human immunodeficiency virus type 1 subtype C gag, pol, and gagpol DNA and alphavirus replicon vaccines.
Megede JZ; Otten GR; Doe B; Liu H; Srivastava R; Greer C; Legg H; Tang T; Polo JM; Donnelly JJ; Ulmer JB; Barnett SW
Vaccine; 2006 Apr; 24(15):2755-63. PubMed ID: 16460840
[TBL] [Abstract][Full Text] [Related]
31. Immunogenicity in pig-tailed macaques of poliovirus replicons expressing HIV-1 and SIV antigens and protection against SHIV-89.6P disease.
Fultz PN; Stallworth J; Porter D; Novak M; Anderson MJ; Morrow CD
Virology; 2003 Oct; 315(2):425-37. PubMed ID: 14585346
[TBL] [Abstract][Full Text] [Related]
32. SIV DNA vaccine co-administered with IL-12 expression plasmid enhances CD8 SIV cellular immune responses in cynomolgus macaques.
Boyer JD; Robinson TM; Kutzler MA; Parkinson R; Calarota SA; Sidhu MK; Muthumani K; Lewis M; Pavlakis G; Felber B; Weiner D
J Med Primatol; 2005 Oct; 34(5-6):262-70. PubMed ID: 16128921
[TBL] [Abstract][Full Text] [Related]
33. Recombinant Kunjin virus replicon vaccines induce protective T-cell immunity against human papillomavirus 16 E7-expressing tumour.
Herd KA; Harvey T; Khromykh AA; Tindle RW
Virology; 2004 Feb; 319(2):237-48. PubMed ID: 14980484
[TBL] [Abstract][Full Text] [Related]
34. Mucosal and systemic SIV-specific cytotoxic CD4
Khanna M; Jackson RJ; Alcantara S; Amarasena TH; Li Z; Kelleher AD; Kent SJ; Ranasinghe C
Sci Rep; 2019 Apr; 9(1):5661. PubMed ID: 30952887
[TBL] [Abstract][Full Text] [Related]
35. Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques.
Chong SY; Egan MA; Kutzler MA; Megati S; Masood A; Roopchard V; Garcia-Hand D; Montefiori DC; Quiroz J; Rosati M; Schadeck EB; Boyer JD; Pavlakis GN; Weiner DB; Sidhu M; Eldridge JH; Israel ZR
Vaccine; 2007 Jun; 25(26):4967-82. PubMed ID: 17335943
[TBL] [Abstract][Full Text] [Related]
36. Subtype AE HIV-1 DNA and recombinant Fowlpoxvirus vaccines encoding five shared HIV-1 genes: safety and T cell immunogenicity in macaques.
De Rose R; Chea S; Dale CJ; Reece J; Fernandez CS; Wilson KM; Thomson S; Ramshaw IA; Coupar BE; Boyle DB; Sullivan MT; Kent SJ
Vaccine; 2005 Mar; 23(16):1949-56. PubMed ID: 15734067
[TBL] [Abstract][Full Text] [Related]
37. Augmentation of SIV DNA vaccine-induced cellular immunity by targeting the 4-1BB costimulatory molecule.
Calarota SA; Hokey DA; Dai A; Jure-Kunkel MN; Balimane P; Weiner DB
Vaccine; 2008 Jun; 26(25):3121-34. PubMed ID: 18336959
[TBL] [Abstract][Full Text] [Related]
38. Macaques co-immunized with SIVgag/pol-HIVenv and IL-12 plasmid have increased cellular responses.
Robinson TM; Sidhu MK; Pavlakis GN; Felber BK; Silvera P; Lewis MG; Eldridge J; Weiner DB; Boyer JD
J Med Primatol; 2007 Aug; 36(4-5):276-84. PubMed ID: 17669216
[TBL] [Abstract][Full Text] [Related]
39. SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251.
Villefroy P; Letourneur F; Coutsinos Z; Mortara L; Beyer C; Gras-Masse H; Guillet JG; Bourgault-Villada I
Virol J; 2006 Aug; 3():65. PubMed ID: 16945152
[TBL] [Abstract][Full Text] [Related]
40. Induction of antigen-specific killer T lymphocyte responses using subunit SIVmac251 gag and env vaccines containing QS-21 saponin adjuvant.
Newman MJ; Munroe KJ; Anderson CA; Murphy CI; Panicali DL; Seals JR; Wu JY; Wyand MS; Kensil CR
AIDS Res Hum Retroviruses; 1994 Jul; 10(7):853-61. PubMed ID: 7986590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
